ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors

Area of Science:

• Immunology
• Extracellular Matrix Biology
• T Cell Differentiation

Background:

• The extracellular matrix (ECM) influences immune cell function and tissue homeostasis.
• Peripheral immune tolerance is critical for preventing autoimmune diseases.
• Regulatory T cells (TR1) play a key role in suppressing immune responses.

Purpose of the Study:

• To investigate the role of ECM components as biosensors for inflammatory microenvironments.
• To identify ECM molecules that can induce regulatory T cells (TR1).
• To elucidate the mechanisms by which ECM influences T cell fate decisions and peripheral tolerance.

Main Methods:

• Murine and human T cell culture systems.
• Analysis of regulatory T cell induction by hyaluronan (HA).
• In vivo studies using a mouse colitis model.
• Investigation of signaling pathways (CD44, p38, ERK1/2) and molecular interactions (osteopontin).
• Use of synthetic matrices to recapitulate TR1 induction.

Main Results:

• Hyaluronan (HA), an ECM component, induces IL-10-producing regulatory T cells (TR1) from conventional T cell precursors.
• Intact HA, found in healing tissues, promotes TR1 induction and abrogates colitis in mice, whereas fragmentary HA, in inflamed tissues, does not.
• TR1 precursor cells are identified as CD4(+)CD62L(-)FoxP3(-) effector memory T cells.
• TR1 induction is mediated by CD44 cross-linking and signaling via p38 and ERK1/2 pathways.
• Osteopontin suppresses HA-induced TR1 induction in a CD44-dependent manner.
• TR1 induction signals can be replicated using synthetic matrices.

Conclusions:

• The ECM acts as a biosensor for inflammatory states, influencing peripheral immune tolerance.
• Hyaluronan's structural integrity is critical for its ability to induce regulatory T cells.
• Matrix integrity cues play a significant role in maintaining peripheral tolerance.
• CD44 signaling integrates matrix cues and molecular signals to regulate T cell fate.
• These findings offer novel strategies for immunomodulation by targeting the ECM microenvironment.